,
Nature Publishing Group
British Journal of Cancer
Evolutionary Intelligence

Schramm, A., Schowe, B., Fielitz, K., Heilmann, M., Martin, M., Marschall, T., … Schulte, J. (2012). Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. British Journal of Cancer, 107, 1409–1417.